Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | March 2012 |
A Phase 1 Clinical Trial of Intra-Tumoral Injection of Human IgM Monoclonal Antibody (MORAb-028) to the Ganglioside GD2 in Subjects With Injectable Metastatic Melanoma
This research is being done to find out the safety of MORAb-028 in subjects with metastatic
melanoma.
We found this trial at
1
site
Click here to add this to my saved trials
